PubMed

Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease.

Kunz R, Friedrich C, Wolbers M, Mann JF.

Ann Intern Med. 2008 Jan 1;148(1):30-48. Epub 2007 Nov 5.PMID: 17984482 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of dual blockade of the renin-angiotensin system in primary proteinuric nephropathies.

Luño J, Barrio V, Goicoechea MA, González C, de Vinuesa SG, Gómez F, Bernis C, Espinosa M, Ahijado F, Gómez J, Escalada P.

Kidney Int Suppl. 2002 Dec;(82):S47-52.PMID: 12410855 [PubMed - indexed for MEDLINE]Related articles

Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension.

Matchar DB, McCrory DC, Orlando LA, Patel MR, Patel UD, Patwardhan MB, Powers B, Samsa GP, Gray RN.

Ann Intern Med. 2008 Jan 1;148(1):16-29. Epub 2007 Nov 5. Review.PMID: 17984484 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?

Weir MR.

Clin Ther. 2007 Sep;29(9):1803-24. Review.PMID: 18035185 [PubMed - indexed for MEDLINE]Related articles

Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: a systematic review of the efficacy and safety data.

MacKinnon M, Shurraw S, Akbari A, Knoll GA, Jaffey J, Clark HD.

Am J Kidney Dis. 2006 Jul;48(1):8-20. Review.PMID: 16797382 [PubMed - indexed for MEDLINE]Related articles

Antiproteinuric response to dual blockade of the renin-angiotensin system in primary glomerulonephritis: meta-analysis and metaregression.

Catapano F, Chiodini P, De Nicola L, Minutolo R, Zamboli P, Gallo C, Conte G.

Am J Kidney Dis. 2008 Sep;52(3):475-85. Epub 2008 May 12.PMID: 18468748 [PubMed - indexed for MEDLINE]Related articles

Pharmacologic management of diabetic nephropathy.

Vivian EM, Rubinstein GB.

Clin Ther. 2002 Nov;24(11):1741-56; discussion 1719. Review.PMID: 12501871 [PubMed - indexed for MEDLINE]Related articles

Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data.

Jafar TH, Schmid CH, Landa M, Giatras I, Toto R, Remuzzi G, Maschio G, Brenner BM, Kamper A, Zucchelli P, Becker G, Himmelmann A, Bannister K, Landais P, Shahinfar S, de Jong PE, de Zeeuw D, Lau J, Levey AS.

Ann Intern Med. 2001 Jul 17;135(2):73-87. Erratum in: Ann Intern Med 2002 Aug 20;137(4):299. PMID: 11453706 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis.

Casas JP, Chua W, Loukogeorgakis S, Vallance P, Smeeth L, Hingorani AD, MacAllister RJ.

Lancet. 2005 Dec 10;366(9502):2026-33. Review.PMID: 16338452 [PubMed - indexed for MEDLINE]Related articles

[The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure]

Bernadet-Monrozies P, Rostaing L, Kamar N, Durand D.

Presse Med. 2002 Nov 9;31(36):1714-20. Review. French. PMID: 12467154 [PubMed - indexed for MEDLINE]Related articles

Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis.

Navaneethan SD, Nigwekar SU, Sehgal AR, Strippoli GF.

Clin J Am Soc Nephrol. 2009 Mar;4(3):542-51. Epub 2009 Mar 4. Review.PMID: 19261819 [PubMed - indexed for MEDLINE]Related articles

Meta-analysis: angiotensin-receptor blockers in chronic heart failure and high-risk acute myocardial infarction.

Lee VC, Rhew DC, Dylan M, Badamgarav E, Braunstein GD, Weingarten SR.

Ann Intern Med. 2004 Nov 2;141(9):693-704. Erratum in: Ann Intern Med. 2005 Mar 1;42(5):391. Dosage error in article text. PMID: 15520426 [PubMed - indexed for MEDLINE]Related articlesFree article

ACE-inhibitor, AT1-receptor-antagonist, or both? A clinical pharmacologist's perspective after publication of the results of ONTARGET.

Schindler C.

Ther Adv Cardiovasc Dis. 2008 Aug;2(4):233-48.PMID: 19124424 [PubMed - indexed for MEDLINE]Related articles

The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker.

Kuti EL, Baker WL, White CM.

Curr Med Res Opin. 2007 Jun;23(6):1239-44. Epub 2007 Apr 23.PMID: 17559720 [PubMed - indexed for MEDLINE]Related articles

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for IgA nephropathy.

Dillon JJ.

Semin Nephrol. 2004 May;24(3):218-24. Review.PMID: 15156527 [PubMed - indexed for MEDLINE]Related articles

Renin-angiotensin-aldosterone system blockade and renal protection: angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers?

Ruilope LM.

Acta Diabetol. 2005 Apr;42 Suppl 1:S33-41. Review.PMID: 15868118 [PubMed - indexed for MEDLINE]Related articles

ACE inhibitors in heart failure: what more do we need to know?

Demers C, Mody A, Teo KK, McKelvie RS.

Am J Cardiovasc Drugs. 2005;5(6):351-9. Review.PMID: 16259523 [PubMed - indexed for MEDLINE]Related articles

Systematic review on urine albumin testing for early detection of diabetic complications.

Newman DJ, Mattock MB, Dawnay AB, Kerry S, McGuire A, Yaqoob M, Hitman GA, Hawke C.

Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. Review.PMID: 16095545 [PubMed - indexed for MEDLINE]Related articlesFree article

Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.

[No authors listed]

Prescrire Int. 2005 Oct;14(79):180-6.PMID: 16285075 [PubMed - indexed for MEDLINE]Related articles

The effects of dual blockade of the renin-angiotensin system on urinary protein and transforming growth factor-beta excretion in 2 groups of patients with IgA and diabetic nephropathy.

Song JH, Lee SW, Suh JH, Kim ES, Hong SB, Kim KA, Kim MJ.

Clin Nephrol. 2003 Nov;60(5):318-26.PMID: 14640237 [PubMed - indexed for MEDLINE]Related articles